Here’s a peek at the latest picks from our Strong Buy Stocks from Top Wall Street Analysts screener:
-
Darling Ingredients (DAR): Top-rated food stock with 40%+ projected upside
-
Haemonetics Corp (HAE): A recent deal could unlock major earnings upside
-
Sandisk Corp (SNDK): Eight top-1% analysts back this memory play
P.S. Get more alerts like this daily … Try WallStreetZen Premium.
A note from our sponsors...
The ONLY AI opportunity you should be looking at
This is the ONLY AI wealth-building opportunity you should be watching right now.
No. It's not about Nvidia, Tesla, or Meta...
It's about one overlooked company profiting off AI "digital goldmines" that are poised to experience 100x growth very soon.
This new opportunity will change the market and make investors a lot of money.
That's why it has received a $500 billion commitment from President Trump himself...
Learn more about this little-known company here >>>
1. Darling Ingredients (NYSE: DAR)
This specialty ingredient and flavoring company stands out as the top-rated stock in its sector, with strong momentum driven by its renewable diesel operations and expanding collagen business.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $61.29 — get current quote
Max 1-year forecast: $88.00
Why we're watching:
- DAR has strong, bullish coverage among the analysts we track, with 5 Strong Buy, 2 Buy, and 1 Hold recommendations. See all recommendations here
- For example, TD Cowen researcher Jason Gabelman (a top 12% rated analyst) maintained her Strong Buy recently maintained a Strong Buy recommendation with a price target pointing to 30%+ upside potential.
- Even better, UBS researcher Manav Gupta (a top 6% rated analyst) recently maintained his Strong Buy recommendation with a price target over 40% above current levels as of writing.
- Industry ranking context: DAR is currently the #1 highest-rated stock in the Food industry.
- Zen Ratings highlights: DAR earns an overall A rating, equal to a Strong Buy recommendation. Stocks in this elite tier have historically delivered nearly 30% annual returns, soundly beating the S&P.
- Component Grades: DAR demonstrates balanced quality with solid Bs for Financials, Growth, Sentiment, Value, and Safety. This combination reflects the company's stable transformation business model and strong positioning in sustainable ingredients. See all 7 Component Grades here
Recent momentum for this blood and plasma supplier stems from the company's non-exclusive supply agreement with CSL, which presents significant earnings upside potential as Haemonetics recaptures market share in the plasma collection space.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $105.30 — get current quote
Max 1-year forecast: $125.00
Why we're watching:
- HAE has strong, bullish coverage among the analysts we track, with 3 Strong Buy, 4 Buy, and 1 Hold recommendations. See all recommendations here
- For example, Citigroup researcher Joanne Wuensch (a top 9% rated analyst) recently upgraded to Strong Buy a price target pointing to nearly 20% upside in the coming year, citing that every 10% market share recapture adds $0.13 to earnings per share.
- Industry ranking context: HAE is currently the #1 highest-rated stock in the Medical industry, which has an Industry Rating of B.
- Zen Ratings highlights: HAE earns an overall A rating, which amounts to a Strong Buy recommendation. Stocks with this rating represent the elite top 5% of all 4,600+ stocks tracked based on a rigorous 115-factor fundamental review.
- Component Grades: HAE excels across multiple dimensions with strong Bs for Financials, Growth, Momentum, Safety, Sentiment, and Value, reflecting the company's robust market position in blood management and the significant opportunity from its CSL partnership. See all 7 Component Grades here
This NAND flash technology company has established datacenter operations as a key growth pillar, deepening customer partnerships while posting exceptional financial results with a profit margin of 77%.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $1,777.80 — get current quote
Max 1-year forecast: $3,050.00
Why we're watching:
- SNDK has broad, bullish coverage among the analysts we track, with 10 Strong Buy, 4 Buy, and 2 Hold recommendations. See all recommendations here
- For example, Rosenblatt researcher Kevin Cassidy (a top 1% rated analyst) recently initiated coverage with a Strong Buy recommendation and price target pointing to 35% upside potential in the coming year.
- That’s mild compared to the street-high target, which points to greater than 70% upside potential. See all recommendations here
- Industry ranking context: SNDK is currently the #1 highest-rated stock in the Computer Hardware industry, which has an Industry Rating of C.
- Zen Ratings highlights: SNDK earns an overall A rating, which is equal to a Strong Buy recommendation. Stocks in this topmost tier have historically delivered nearly 30% annual returns, soundly beating the S&P.
- Component Grades: SNDK demonstrates exceptional strength with As for Financials and Growth, combined with solid Bs for Momentum and Value. This combination reflects the company's outstanding profitability and its leadership position in the datacenter storage revolution. See all 7 Component Grades here
What to Do Next?